Search
Cardio Diagnostics Holdings Inc
CDIOAdd to Watchlist
1.550USD
-0.130-7.74%
Close 05/15, 16:00（ET）Quotes delayed by 15 min
4.59MMarket Cap
0.06P/E TTM
More Details of Cardio Diagnostics Holdings Inc Company
Cardio Diagnostics Holdings, Inc. is an artificial intelligence-powered precision cardiovascular medicine company. The Company develops and commercializes a series of products for various types of cardiovascular disease and associated co-morbidities, including coronary heart disease (CHD), stroke, heart failure and diabetes, by leveraging its artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine. Its first product, Epi+Gen CHD, is an epigenetics-based clinical blood test capable of assessing near-term (three-year) risk for CHD, and its second product, PrecisionCHD, is an epigenetics-based clinical blood test for the detection of CHD. CardioInnovate360 is a research use only (RUO) solution to support the discovery, development, and validation of biopharmaceuticals for the assessment and management of cardiovascular diseases. HeartRisk is a cardiovascular risk intelligence platform that combines insights from anonymized and aggregated clinical cardiovascular data.
Cardio Diagnostics Holdings Inc Info
Ticker SymbolCDIO
Company nameCardio Diagnostics Holdings Inc
IPO dateNov 23, 2021
CEODogan (Meeshanthini V)
Number of employees13
Security typeOrdinary Share
Fiscal year-endNov 23
Address311 W. Superior Street
CityCHICAGO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code60645
Phone18552269991
Website
Ticker SymbolCDIO
IPO dateNov 23, 2021
CEODogan (Meeshanthini V)
Company Executives of Cardio Diagnostics Holdings Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Timur Dogan, Ph.D.
Mr. Timur Dogan, Ph.D.
Chief Technology Officer
Chief Technology Officer
107.26K
+96.01%
Dr. Warren Hosseinion, M.D.
Dr. Warren Hosseinion, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
3.87K
--
Dr. Robert Philibert, M.D., Ph.D.
Dr. Robert Philibert, M.D., Ph.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
3.25K
--
Mr. James Intrater
Mr. James Intrater
Independent Director
Independent Director
2.39K
--
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Elisa Luqman, Esq., J.D.
Ms. Elisa Luqman, Esq., J.D.
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Paul F. Burton, J.D.
Mr. Paul F. Burton, J.D.
Independent Director
Independent Director
--
--
Ms. Wendy J. Betts
Ms. Wendy J. Betts
Independent Director
Independent Director
--
--
Mr. Peter K. Fung
Mr. Peter K. Fung
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Timur Dogan, Ph.D.
Mr. Timur Dogan, Ph.D.
Chief Technology Officer
Chief Technology Officer
107.26K
+96.01%
Dr. Warren Hosseinion, M.D.
Dr. Warren Hosseinion, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
3.87K
--
Dr. Robert Philibert, M.D., Ph.D.
Dr. Robert Philibert, M.D., Ph.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
3.25K
--
Mr. James Intrater
Mr. James Intrater
Independent Director
Independent Director
2.39K
--
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Elisa Luqman, Esq., J.D.
Ms. Elisa Luqman, Esq., J.D.
Chief Financial Officer
Chief Financial Officer
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Thu, May 14
Updated: Thu, May 14
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Dogan (Timur)
3.62%
Jane Street Capital, L.L.C.
2.75%
Dogan (Meeshanthini)
2.50%
Bd Holding, Inc
1.79%
DRW Securities, LLC
1.37%
Other
87.98%
Shareholders
Shareholders
Proportion
Dogan (Timur)
3.62%
Jane Street Capital, L.L.C.
2.75%
Dogan (Meeshanthini)
2.50%
Bd Holding, Inc
1.79%
DRW Securities, LLC
1.37%
Other
87.98%
Shareholder Types
Shareholders
Proportion
Individual Investor
6.52%
Investment Advisor
3.72%
Corporation
1.79%
Investment Advisor/Hedge Fund
0.51%
Hedge Fund
0.40%
Other
87.06%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
38
138.49K
4.68%
-23.97K
2025Q4
39
115.09K
6.22%
--
2025Q3
41
115.09K
6.70%
+30.25K
2025Q2
39
84.84K
5.90%
+274.00
2025Q1
35
84.57K
5.41%
-9.47K
2024Q4
39
85.72K
5.08%
+29.79K
2024Q3
59
55.93K
19.52%
-4.45K
2024Q2
61
60.37K
27.33%
+6.29K
2024Q1
58
54.08K
29.21%
-151.37K
2023Q4
58
55.21K
23.41%
+40.18K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Dogan (Timur)
4.28K
0.14%
--
--
Aug 25, 2025
Dogan (Meeshanthini)
55.18K
1.86%
--
--
Aug 25, 2025
Bd Holding, Inc
52.88K
1.79%
--
--
Aug 25, 2025
DRW Securities, LLC
40.46K
1.37%
+22.30K
+122.75%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
35.57K
1.2%
--
--
Dec 31, 2025
Geode Capital Management, L.L.C.
15.13K
0.51%
+37.00
+0.25%
Dec 31, 2025
Citadel Advisors LLC
10.86K
0.37%
-8.66K
-44.38%
Dec 31, 2025
UBS Financial Services, Inc.
952.00
0.03%
+952.00
--
Dec 31, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
May 08, 2025
Merger
30→1
Date
Ex-dividend Date
Type
Ratio
May 08, 2025
Merger
30→1
